semaglutide poisoning Poison control data shows significant increase in weight-loss drug overdoses Thousands overdosed on Ozempic, Wegovy

Clinical trials show average weight loss of 14.9% at the 2.4 mg dose over 68 weeks

The comparison between injectable and oral delivery methods extends beyond semaglutide to the broader peptide landscape

Studies have shown that semaglutide can significantly reduce blood sugar levels and help prevent complications like heart disease

Ozempic lawsuits have been filed by people who were diagnosed with stomach paralysis or blindness after using the drug for weight-loss and diabetes

DECLARATIONS Authors contributions Drafted the manuscript: Valds-Calero I Revised the manuscript critically for important intellectual content: Rodrguez A, Frhbeck G All authors participated in final approval of the version to be published

doi: 10.1161/01.CIR.0000133317.49796.0E